New Covid-19 vaccine demonstrates ‘89% efficacy’

The new vaccine is called NVX-CoV2373 (David Cheskin/PA)

An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax.

The UK has secured access to 60 million doses of the vaccine, called NVX-CoV2373.